A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
Clinical trial NCT01644500 · COMPLETED
Trial details
- NCT number
- NCT01644500
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-08-01
- Enrollment
- 737
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.